Regenerative Polypeptides and Uses Thereof
    3.
    发明公开

    公开(公告)号:US20230312663A1

    公开(公告)日:2023-10-05

    申请号:US18163210

    申请日:2023-02-01

    IPC分类号: C07K14/50 A61P19/02

    CPC分类号: C07K14/50 A61P19/02

    摘要: Described herein are polypeptides comprising an FGF17, IGF2, or BMP7 amino acid sequence and an amino acid sequence from a heterologous polypeptide useful for the treatment of soft-tissue and muscle diseases, disorders, and injuries. Also described herein are synergistic combinations of a Fibroblast Growth Factor Receptor agonist and a glycosaminoglycan, an Insulin-like Growth Factor 1 Receptor (IGF1R) agonist and a short chain fatty acid, and BMP receptor agonists and mTOR activators and/or glycosaminoglycans. Also described are methods of treating muscle and soft-tissue diseases comprising administering the polypeptides and/or synergistic compositions.

    Regenerative Polypeptides and Uses Thereof
    7.
    发明公开

    公开(公告)号:US20230398187A1

    公开(公告)日:2023-12-14

    申请号:US17843748

    申请日:2020-12-22

    IPC分类号: A61K38/30 A61K31/19 A61P21/06

    CPC分类号: A61K38/30 A61K31/19 A61P21/06

    摘要: Described herein are polypeptides comprising an FGF17, IGF2, or BMP? amino acid sequence and an amino acid sequence from a heterologous polypeptide useful for the treatment of soft-tissue and muscle diseases, disorders, and injuries. Also described herein are synergistic combinations of a Fibroblast Growth Factor Receptor agonist and a glycosaminoglycan, an Insulin-like Growth Factor 1 Receptor (IGF1R) agonist and a short chain fatty acid, and BMP receptor agonists and mTOR activators and/or glycosaminoglycans. Also described are methods of treating muscle and soft-tissue diseases comprising administering the polypeptides and/or synergistic compositions.